Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.19 -0.42 (-26.09%)
At close: Sep 30, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Interest Expenses (2018 - 2023)

Updated

Chemomab Therapeutics' Interest Expenses was -$431,000 in Q4 2023, compared with -$380,000 a year earlier.

Analysis

Chemomab Therapeutics (CMMB) Interest Expenses (2018 - 2023) Analysis & Trends

For FY2023, Interest Expenses at Chemomab Therapeutics came in at -$1.24 million.

  • In earlier years, Interest Expenses was -$353,000 in FY2022, $111,000 in FY2021, $6,000 in FY2020 (-33.3%) and $9,000 in FY2019 (-99.4%).
  • The Q4 2023 figure marks the lowest quarterly Interest Expenses since Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Chemomab Therapeutics 8.56 Mn 8.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -431,000.00
Sep 30, 2023 -231,000.00
Jun 30, 2023 -259,000.00
Dec 31, 2022 -380,000.00
Sep 30, 2022 -237,000.00
Jun 30, 2022 480,000.00
Sep 30, 2019 12.58 Mn
Jun 30, 2019 -2.75 Mn
Dec 31, 2018 -212,000.00
Sep 30, 2018 72,000.00
Jun 30, 2018 1.61 Mn
API Access

Chemomab Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=CMMB&period=max&api_key=YOUR_API_KEY